IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,998,000 | -38.1% | 271,534 | -6.7% | 0.00% | -25.0% |
Q1 2022 | $4,847,000 | -14.0% | 291,119 | -1.5% | 0.00% | 0.0% |
Q4 2021 | $5,639,000 | -22.6% | 295,415 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $7,285,000 | -6.6% | 295,415 | -1.5% | 0.01% | -16.7% |
Q2 2021 | $7,801,000 | -21.9% | 299,820 | -5.0% | 0.01% | -25.0% |
Q1 2021 | $9,994,000 | -35.6% | 315,678 | -5.7% | 0.01% | -33.3% |
Q4 2020 | $15,529,000 | +49.8% | 334,685 | +6.3% | 0.01% | +33.3% |
Q3 2020 | $10,365,000 | +25.0% | 314,862 | +4.2% | 0.01% | +12.5% |
Q2 2020 | $8,294,000 | +6.2% | 302,145 | +15.8% | 0.01% | -11.1% |
Q1 2020 | $7,813,000 | -9.9% | 260,984 | -16.7% | 0.01% | +12.5% |
Q4 2019 | $8,672,000 | +56.5% | 313,284 | +2.9% | 0.01% | +33.3% |
Q3 2019 | $5,542,000 | -3.4% | 304,523 | +30.1% | 0.01% | -14.3% |
Q2 2019 | $5,740,000 | +127.2% | 234,100 | -11.9% | 0.01% | +133.3% |
Q1 2019 | $2,526,000 | -0.4% | 265,600 | -7.3% | 0.00% | -25.0% |
Q4 2018 | $2,535,000 | +128.6% | 286,440 | +190.7% | 0.00% | +300.0% |
Q3 2018 | $1,109,000 | -17.9% | 98,540 | -6.5% | 0.00% | -50.0% |
Q2 2018 | $1,350,000 | -20.0% | 105,440 | +5.6% | 0.00% | 0.0% |
Q1 2018 | $1,687,000 | – | 99,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |